Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8.5B | 11.55%7.78B | 8.52%30.65B | 12.24%7.43B | 2.96%6.97B | 10.16%28.24B | 9.01%7.61B | 13.13%7.24B | 10.08%6.62B | 8.47%6.77B |
| Cost of revenue | 5.64B | 12.82%4.6B | 7.23%18.78B | 9.07%4.52B | -1.33%4.07B | 13.13%17.52B | 2.18%4.5B | 17.23%4.75B | 13.73%4.15B | 21.80%4.13B |
| Gross profit | 2.85B | 9.77%3.18B | 10.63%11.86B | 17.54%2.91B | 9.66%2.9B | 5.62%10.72B | 20.68%3.11B | 6.06%2.49B | 4.47%2.48B | -7.39%2.64B |
| Operating expense | 1.17B | 6.34%871.05M | 1.83%3.54B | -11.89%768.02M | -6.42%819.1M | 13.90%3.47B | 1.08%815.05M | 18.44%911.4M | 23.92%871.7M | 13.64%875.26M |
| Operating profit | 1.69B | 11.12%2.31B | 14.85%8.32B | 33.51%2.14B | 17.63%2.08B | 2.07%7.25B | 29.61%2.3B | 0.03%1.58B | -3.74%1.61B | -15.17%1.77B |
| Net non-operating interest income (expenses) | 8.68M | 549.65%5.5M | 1,090.07%5.03M | 3,396.43%923K | 2,114.29%846K | -95.05%423K | -68.28%736K | -109.53%-243K | -101.17%-28K | -103.30%-42K |
| Non-operating interest income | --11.17M | 232.62%6.87M | 38.18%9.89M | 44.38%2.07M | 42.19%2.07M | -54.90%7.16M | -47.61%2.05M | -46.00%2.22M | -63.96%1.43M | -62.43%1.45M |
| Non-operating interest expense | --2.49M | 12.79%1.38M | -27.91%4.85M | -21.56%1.15M | -18.39%1.22M | -8.04%6.73M | -17.39%1.31M | 57.47%2.47M | -7.18%1.46M | -42.39%1.5M |
| Net investment income | 1.99M | -14,600.00%-3.19M | 150.55%64.54M | -27.30%5.25M | 100.89%22K | -27.46%25.76M | -40.25%21.01M | 0 | 57.53%7.22M | -479.11%-2.47M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 14.01M | 230.40%8.44M | -70.55%5.51M | 187.10%27K | -86.24%2.55M | -6.90%18.69M | 80.00%9K | -99.06%164K | -338.46%-31K | 586.82%18.55M |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -274.21M | -2,694.44%-2.18B | -136.25%-117.85M | -38,343.54%-151.06M | 1,758.88%83.99M | 9.89%-49.88M | 15.65%-44.77M | 62.66%-447K | -57.57%395K | -150.89%-5.06M |
| Less:Restructuring and mergern&acquisition | --4.68M | -77.40%23.19M | --272.34M | --169.37M | --102.58M | --0 | ---- | ---- | --0 | --0 |
| Less:Other special charges | ---8.14M | ---- | -849.03%-194.23M | -3,204.51%-18.31M | -919.35%-186.57M | 69.85%25.93M | 243.30%44.57M | -81.87%217K | 40.49%-554K | -1,006.99%-18.3M |
| Less:Write off | --277.67M | --2.16B | 65.92%39.74M | --0 | --0 | -40.25%23.95M | -99.51%198K | --230K | --159K | --23.37M |
| Other non-operating income (expenses) | -17.04M | 134.74%3.63M | -120.11%-5.97M | -126.76%-954K | -206.08%-10.46M | 2.81%29.7M | 36.35%8.42M | 19.48%7.86M | -67.04%3.57M | 85.17%9.86M |
| Income before tax | 1.42B | -93.37%142.89M | 13.79%8.28B | 23.58%2B | 20.57%2.15B | 1.88%7.27B | 29.47%2.28B | -0.85%1.59B | -4.15%1.62B | -14.45%1.79B |
| Income tax | 484.94M | -90.98%58.83M | 10.20%2.28B | 1.19%557.84M | 12.46%652.28M | -3.61%2.07B | 16.92%529.13M | -20.64%410.41M | 3.27%551.26M | -10.04%579.99M |
| Net income | 935.46M | -94.40%84.06M | 15.22%5.99B | 35.15%1.44B | 24.46%1.5B | 4.24%5.2B | 33.81%1.75B | 8.59%1.18B | -7.59%1.07B | -16.41%1.21B |
| Net income continuous operations | --935.46M | -94.40%84.06M | 15.22%5.99B | 35.15%1.44B | 24.46%1.5B | 4.24%5.2B | 33.81%1.75B | 8.59%1.18B | -7.59%1.07B | -16.42%1.21B |
| Noncontrolling interests | 1.84M | 4.93M | ||||||||
| Net income attributable to the company | 933.62M | -94.73%79.13M | 15.22%5.99B | 35.15%1.44B | 24.46%1.5B | 4.24%5.2B | 33.81%1.75B | 8.59%1.18B | -7.59%1.07B | -16.41%1.21B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 933.62M | -94.73%79.13M | 15.22%5.99B | 35.15%1.44B | 24.46%1.5B | 4.24%5.2B | 33.81%1.75B | 8.59%1.18B | -7.59%1.07B | -16.41%1.21B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 10.08 | -94.60%0.855 | 20.42%64.005 | 42.22%15.345 | 29.52%15.84 | 5.33%53.15 | 36.48%18.07 | 10.04%12.06 | -7.38%10.79 | -16.29%12.23 |
| Diluted earnings per share | 9.95 | -94.61%0.845 | 20.48%63.27 | 42.31%15.185 | 29.61%15.67 | 5.43%52.515 | 36.69%17.845 | 10.12%11.91 | -7.26%10.67 | -16.25%12.09 |
| Dividend per share | 0 | 0 | 15.38%37.5 | 15.63%18.5 | 0 | 22.64%32.5 | 17.86%16.5 | 0 | 28.00%16 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |